Scarica l'app Stockscreener
111.01
2.54%
2.75
Pre-mercato:
110.82
-0.19
-0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$108.26
Aprire:
$108.97
Volume 24 ore:
11.96M
Relative Volume:
0.90
Capitalizzazione di mercato:
$275.53B
Reddito:
$63.90B
Utile/perdita netta:
$19.05B
Rapporto P/E:
14.68
EPS:
7.5596
Flusso di cassa netto:
$13.05B
1 W Prestazione:
+2.22%
1M Prestazione:
+10.68%
6M Prestazione:
+32.68%
1 anno Prestazione:
+11.40%
Intervallo 1D:
$107.95
$111.22
Intervallo di 1 settimana:
$107.22
$112.90
Portata 52W:
$73.31
$112.90
Merck Co Inc Stock (MRK) Company Profile
Nome
Merck Co Inc
Settore
Industria
Telefono
908-740-4000
Indirizzo
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Confronta MRK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
111.01 | 268.70B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,073.29 | 964.11B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
218.55 | 514.75B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
221.89 | 390.15B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
146.16 | 271.72B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-08 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-10-13 | Ripresa | Citigroup | Neutral |
| 2025-09-17 | Downgrade | Berenberg | Buy → Hold |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-08 | Downgrade | Truist | Buy → Hold |
| 2024-12-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Ripresa | BofA Securities | Buy |
| 2024-12-04 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-11 | Downgrade | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-03-11 | Downgrade | Societe Generale | Hold → Sell |
| 2024-01-04 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-27 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Aggiornamento | UBS | Neutral → Buy |
| 2023-07-14 | Iniziato | HSBC Securities | Hold |
| 2023-04-13 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-03-28 | Downgrade | Societe Generale | Buy → Hold |
| 2023-03-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Iniziato | Jefferies | Buy |
| 2023-02-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-10-10 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-09-14 | Aggiornamento | Berenberg | Hold → Buy |
| 2022-07-06 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Ripresa | SVB Leerink | Outperform |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-16 | Iniziato | Daiwa Securities | Neutral |
| 2021-12-13 | Downgrade | UBS | Buy → Neutral |
| 2021-12-09 | Iniziato | Wells Fargo | Overweight |
| 2021-12-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-11-29 | Downgrade | Citigroup | Buy → Neutral |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Aggiornamento | Argus | Hold → Buy |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-05-20 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-08-03 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-06-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-16 | Iniziato | SVB Leerink | Outperform |
| 2019-07-03 | Iniziato | Mizuho | Buy |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-05-13 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Reiterato | Citigroup | Buy |
| 2018-10-09 | Ripresa | Guggenheim | Buy |
| 2018-04-23 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-04-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Reiterato | Leerink Partners | Mkt Perform |
| 2018-02-07 | Reiterato | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Aggiornamento | SunTrust | Hold → Buy |
Mostra tutto
Merck Co Inc Borsa (MRK) Ultime notizie
Merck stock rises as $70 billion growth target sharpens focus ahead of Feb. 3 earnings - TechStock²
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.
Merck & Co., Inc. (NYSE:MRK) Stock Acquired Rep. Gilbert Ray Cisneros, Jr. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Up 2.4%Should You Buy? - MarketBeat
Manning & Napier Advisors LLC Has $15.67 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Kera Capital Partners Inc. Buys 9,382 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. (NYSE:MRK) Presents a Compelling Value Investment Case - Chartmill
Eastern Bank Sells 47,755 Shares of Merck & Co., Inc. $MRK - MarketBeat
Is Merck & Co Inc Gaining or Losing Market Support? - Benzinga
J.P. Morgan: Revolution Awaits Key Readout As Merck Takeover Rumors Swirl - Citeline News & Insights
Nordea Investment Management AB Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by S Bank Fund Management Ltd - MarketBeat
RWC Asset Management LLP Has $18.42 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
MGO One Seven LLC Increases Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Down 1.2%Here's Why - MarketBeat
Merck Wants to Do More Multi Tens of Billion-Dollar Deals - Bloomberg.com
Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s - Reuters
AirNexis Launches To Take On Merck In Expanding PDE3/4i COPD Field - Citeline News & Insights
Merck & Co., Inc. $MRK Shares Sold by Tokio Marine Asset Management Co. Ltd. - MarketBeat
Sumitomo Mitsui Trust Group Inc. Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Tema Etfs LLC Acquires 39,849 Shares of Merck & Co., Inc. $MRK - MarketBeat
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $31.72 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Godsey & Gibb Inc. - MarketBeat
MRK Stock Price, Forecast & Analysis | MERCK & CO. INC. (NYSE:MRK) - Chartmill
Merck (MRK) stock week ahead: $30 billion Revolution talks and JPMorgan catalysts to watch - TechStock²
New York State Teachers Retirement System Lowers Stock Position in Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Price and Chart — NYSE:MRK - TradingView — Track All Markets
Key deals this week: Merck, Glencore, CrowdStrike, Marvell Technology, Steel Dynamics and more - Seeking Alpha
Merck & Co., Inc. $MRK Shares Purchased by Sumitomo Mitsui DS Asset Management Company Ltd - MarketBeat
Narwhal Capital Management Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Eikon Therapeutics Files for IPO Led By Merck Veterans - Bloomberg.com
Merck in Talks to Buy Revolution Medicines Per Financial Times Report - Finviz
Merck (MRK) stock today: $32 billion Revolution talks and CDC vaccine shift put Feb. 3 in play - TechStock²
Oregon Public Employees Retirement Fund Buys 68,594 Shares of Merck & Co., Inc. $MRK - MarketBeat
Nisa Investment Advisors LLC Sells 125,886 Shares of Merck & Co., Inc. $MRK - MarketBeat
Next Level Private LLC Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Park Avenue Securities LLC Acquires 18,839 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck in Talks to Buy Biotech Revolution Medicines, FT Says - Bloomberg.com
Merck reportedly consiering a major acquisition (Revolution Medicines) - marketscreener.com
Merck & Co., Inc. $MRK Shares Acquired by Capital Investment Advisors LLC - MarketBeat
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight - Benzinga
Where is Merck & Co. (MRK) headed according to Wall Street? - MSN
Wells Fargo adds Merck (MRK) to Q1 2026 tactical list ahead of key catalysts - MSN
Wells Fargo Adds Merck (MRK) to Q1 2026 Tactical List Ahead of Key Catalysts - Finviz
Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list - Reuters
Merck & Co., Inc. (NYSE:MRK) Shares Up 2.1% Following Analyst Upgrade - MarketBeat
Merck might buy Revolution Medicines - breakingthenews.net
Merck upgraded, AbbVie downgraded at Wolfe (MRK:NYSE) - Seeking Alpha
Why Merck (MRK) is a Top Growth Stock for the Long-Term - Yahoo Finance Singapore
Merck & Co., Inc. (NYSE:MRK) Stock Rating Upgraded by Wolfe Research - MarketBeat
United Asset Strategies Inc. Acquires 21,765 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Azioni (MRK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.21%
1.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):